KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $363.7 million.

  • Zimmer Biomet Holdings' Free Cash Flow rose 355.92% to $363.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 866.51%. This contributed to the annual value of $1.3 billion for FY2024, which is 39.52% up from last year.
  • Per Zimmer Biomet Holdings' latest filing, its Free Cash Flow stood at $363.7 million for Q3 2025, which was up 355.92% from $328.1 million recorded in Q2 2025.
  • Over the past 5 years, Zimmer Biomet Holdings' Free Cash Flow peaked at $525.6 million during Q4 2023, and registered a low of $172.9 million during Q1 2024.
  • Moreover, its 5-year median value for Free Cash Flow was $316.7 million (2024), whereas its average is $318.2 million.
  • Data for Zimmer Biomet Holdings' Free Cash Flow shows a peak YoY increase of 64930.36% (in 2021) and a maximum YoY decrease of 5186.27% (in 2021) over the last 5 years.
  • Over the past 5 years, Zimmer Biomet Holdings' Free Cash Flow (Quarter) stood at $288.4 million in 2021, then crashed by 37.31% to $180.8 million in 2022, then skyrocketed by 190.71% to $525.6 million in 2023, then fell by 13.47% to $454.8 million in 2024, then fell by 20.03% to $363.7 million in 2025.
  • Its last three reported values are $363.7 million in Q3 2025, $328.1 million for Q2 2025, and $338.2 million during Q1 2025.